Stay updated on Canagliflozin Impact on Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Canagliflozin Impact on Heart Failure Clinical Trial page.

Latest updates to the Canagliflozin Impact on Heart Failure Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov footer revision marker updated from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check13 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe History page now displays a new revision label, v3.7.0, replacing the previous v3.6.6. This indicates a platform update that changes the page's versioning and presentation without altering study data.SummaryDifference0.1%

- Check55 days agoChange DetectedA new revision label was added (v3.6.6) replacing the previous v3.6.5 in the page's history. This reflects a backend update to the record history interface rather than changes to the study data.SummaryDifference0.1%

- Check76 days agoChange DetectedA new revision (v3.6.5) was added to the Study Record Versions and the previous revision (v3.6.4) was removed, updating the record's version history. This is a metadata update and does not change the study content.SummaryDifference0.1%

- Check91 days agoChange DetectedA new revision entry (v3.6.4) was added to the record history and the previous revision (v3.6.3) was removed. The change reflects an internal versioning update to the page rather than an alteration to trial data or visible content.SummaryDifference0.1%

Stay in the know with updates to Canagliflozin Impact on Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Canagliflozin Impact on Heart Failure Clinical Trial page.